18F flurpiridaz PET MPI: Imaging characteristics and clinical trials

By sjmartinez • April 4, 2025

Maddahi J. ¹⁸F flurpiridaz PET MPI: Imaging characteristics and clinical trials. J Nucl Cardiol. 2025 Mar;45S:102175. doi: 10.1016/j.nuclcard.2025.102175. Epub 2025 Mar 28. PMID: 40180504.

Tags: (18)F flurpiridaz, Cardiology/Epi, myocardial perfusion imaging, PET MPI, PET tracers, Positron emission tomography, Publications

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment of Cardiometabolic Disease

Anker SD, Ji L, Kindel T, Coats AJ, Ojji D, Barragán AP, Rossing P, Zieroth S, Ahmad S, Usman S, Appannah G, Bailey AL, Bennis[...]

The frequency and impact of previous admissions within 90 days of subsequent hospitalization for acute myocarditis: An analysis of the Nationwide readmission database

Afzal A, Qureshi A, Bozkurt B, Fonarow GC, Lip GYH, Kwok CS. The frequency and impact of previous admissions within 90 days of subsequent hospitalization[...]

Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity

Shakil SS, Hsue PY. Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity. Circ Heart Fail. 2026 Mar 11:e014088. doi: 10.1161/CIRCHEARTFAILURE.126.014088. Epub ahead of[...]